{
"info": {
"nct_id": "NCT00238394",
"official_title": "A Phase II Study of AZD2171 in Patients With Locally Advanced or Metastatic Hepatocellular Carcinoma",
"inclusion_criteria": "* Histologically confirmed hepatocellular carcinoma\n\n * Locally advanced or metastatic disease\n * Not amenable to treatment with surgery or orthotopic liver transplantation\n* Measurable or non-measurable disease\n\n * Measurable disease is defined as ≥ 1 unidimensionally measurable lesion ≥ 20 mm by conventional techniques OR ≥ 10 mm by spiral CT scan\n* Evidence of disease progression by imaging on serial exams or biochemical evidence of a rising alpha fetoprotein on serial testing\n* No history of brain metastases other than locally treatable CNS lesions (i.e., lesions treatable with surgery or radiosurgery)\n\n * Patients with locally treatable CNS disease eligible provided they were previously treated and had no evidence of CNS progression for ≥ 4 weeks after completion of treatment\n* No fibrolamellar hepatocellular carcinoma or mixed cholangiocarcinoma/hepatocellular carcinoma\n* Performance status - ECOG 0-1\n* Absolute neutrophil count ≥ 1,200/mm^3\n* Platelet count ≥ 75,000/mm^3\n* Hemoglobin ≥ 10.0 g/dL\n* Bilirubin ≤ 3 times upper limit of normal (ULN)\n* AST ≤ 5 times ULN\n* Alkaline phosphatase ≤ 5 times ULN\n* Urine protein < 1+ by urine dip stick OR proteinuria < 1 gm/24-hour collection\n* QTc prolongation ≤ 500 msec\n* No symptomatic congestive heart failure\n* No unstable angina pectoris\n* No cardiac arrhythmia\n* No uncontrolled blood pressure, defined as systolic blood pressure > 150 mm Hg and/or diastolic blood pressure > 100 mm Hg\n* No significant ECG abnormality within the past 14 days\n* No New York Heart Association class III or IV disease\n* Not pregnant or nursing\n* Negative pregnancy test\n* Fertile patients must use effective contraception\n* No other malignancy within the past 5 years except basal cell or squamous cell skin cancer or carcinoma in situ of the cervix\n* No history of allergic reaction to compounds of similar chemical or biological composition to AZD2171\n* No ongoing or active infection\n* No psychiatric illness or social situation that would preclude study participation\n* No other uncontrolled illness\n* More than 4 weeks since prior biologic therapy\n* More than 4 weeks since prior and no concurrent immunotherapy\n* No colony-stimulating factors during the first course of study treatment\n* At least 6 weeks since prior chemoembolization\n\n * Patients must have evidence of disease progression or new metastases after prior chemoembolization\n* No prior systemic chemotherapy for this cancer\n* No other concurrent chemotherapy\n* More than 4 weeks since prior hormonal therapy\n* See Disease Characteristics\n* At least 6 weeks since prior radiofrequency ablation or other local ablative therapy\n\n * Patients must have evidence of disease progression or new metastases after prior radiofrequency ablation or other local ablative therapy\n* No prior external beam radiotherapy to the primary site\n* No prior radiotherapy to ≥ 25% of the bone marrow\n* No concurrent radiotherapy\n* See Disease Characteristics\n* No concurrent combination antiretroviral therapy for HIV-positive patients\n* No concurrent drugs or biologics with proarrhythmic potential\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Histologically confirmed hepatocellular carcinoma",
"criterions": [
{
"exact_snippets": "Histologically confirmed hepatocellular carcinoma",
"criterion": "hepatocellular carcinoma",
"requirements": [
{
"requirement_type": "confirmation method",
"expected_value": "histologically confirmed"
}
]
}
]
},
{
"line": "* Locally advanced or metastatic disease",
"criterions": [
{
"exact_snippets": "Locally advanced",
"criterion": "disease stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "locally advanced"
}
]
},
{
"exact_snippets": "metastatic disease",
"criterion": "disease stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "metastatic"
}
]
}
]
},
{
"line": "* Not amenable to treatment with surgery or orthotopic liver transplantation",
"criterions": [
{
"exact_snippets": "Not amenable to treatment with surgery",
"criterion": "treatment with surgery",
"requirements": [
{
"requirement_type": "amenability",
"expected_value": false
}
]
},
{
"exact_snippets": "Not amenable to treatment with ... orthotopic liver transplantation",
"criterion": "treatment with orthotopic liver transplantation",
"requirements": [
{
"requirement_type": "amenability",
"expected_value": false
}
]
}
]
},
{
"line": "* Measurable or non-measurable disease",
"criterions": [
{
"exact_snippets": "Measurable or non-measurable disease",
"criterion": "disease measurability",
"requirements": [
{
"requirement_type": "measurability",
"expected_value": [
"measurable",
"non-measurable"
]
}
]
}
]
},
{
"line": "* Measurable disease is defined as ≥ 1 unidimensionally measurable lesion ≥ 20 mm by conventional techniques OR ≥ 10 mm by spiral CT scan",
"criterions": [
{
"exact_snippets": "Measurable disease is defined as ≥ 1 unidimensionally measurable lesion ≥ 20 mm by conventional techniques",
"criterion": "unidimensionally measurable lesion",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "N/A"
}
},
{
"requirement_type": "size",
"expected_value": {
"operator": ">=",
"value": 20,
"unit": "mm"
}
},
{
"requirement_type": "measurement technique",
"expected_value": "conventional techniques"
}
]
},
{
"exact_snippets": "Measurable disease is defined as ... ≥ 10 mm by spiral CT scan",
"criterion": "unidimensionally measurable lesion",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "N/A"
}
},
{
"requirement_type": "size",
"expected_value": {
"operator": ">=",
"value": 10,
"unit": "mm"
}
},
{
"requirement_type": "measurement technique",
"expected_value": "spiral CT scan"
}
]
}
]
},
{
"line": "* Evidence of disease progression by imaging on serial exams or biochemical evidence of a rising alpha fetoprotein on serial testing",
"criterions": [
{
"exact_snippets": "Evidence of disease progression by imaging on serial exams",
"criterion": "disease progression",
"requirements": [
{
"requirement_type": "evidence",
"expected_value": "imaging on serial exams"
}
]
},
{
"exact_snippets": "biochemical evidence of a rising alpha fetoprotein on serial testing",
"criterion": "alpha fetoprotein",
"requirements": [
{
"requirement_type": "evidence",
"expected_value": "biochemical"
},
{
"requirement_type": "trend",
"expected_value": "rising"
}
]
}
]
},
{
"line": "* No history of brain metastases other than locally treatable CNS lesions (i.e., lesions treatable with surgery or radiosurgery)",
"criterions": [
{
"exact_snippets": "No history of brain metastases",
"criterion": "brain metastases",
"requirements": [
{
"requirement_type": "history",
"expected_value": false
}
]
},
{
"exact_snippets": "other than locally treatable CNS lesions (i.e., lesions treatable with surgery or radiosurgery)",
"criterion": "CNS lesions",
"requirements": [
{
"requirement_type": "treatability",
"expected_value": [
"surgery",
"radiosurgery"
]
}
]
}
]
},
{
"line": "* Patients with locally treatable CNS disease eligible provided they were previously treated and had no evidence of CNS progression for ≥ 4 weeks after completion of treatment",
"criterions": [
{
"exact_snippets": "Patients with locally treatable CNS disease",
"criterion": "CNS disease",
"requirements": [
{
"requirement_type": "treatability",
"expected_value": "locally treatable"
}
]
},
{
"exact_snippets": "provided they were previously treated",
"criterion": "CNS disease treatment",
"requirements": [
{
"requirement_type": "treatment status",
"expected_value": "previously treated"
}
]
},
{
"exact_snippets": "no evidence of CNS progression",
"criterion": "CNS progression",
"requirements": [
{
"requirement_type": "evidence",
"expected_value": false
}
]
},
{
"exact_snippets": "for ≥ 4 weeks after completion of treatment",
"criterion": "CNS progression",
"requirements": [
{
"requirement_type": "duration since treatment",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* No fibrolamellar hepatocellular carcinoma or mixed cholangiocarcinoma/hepatocellular carcinoma",
"criterions": [
{
"exact_snippets": "No fibrolamellar hepatocellular carcinoma",
"criterion": "fibrolamellar hepatocellular carcinoma",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No ... mixed cholangiocarcinoma/hepatocellular carcinoma",
"criterion": "mixed cholangiocarcinoma/hepatocellular carcinoma",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Performance status - ECOG 0-1",
"criterions": [
{
"exact_snippets": "Performance status - ECOG 0-1",
"criterion": "performance status",
"requirements": [
{
"requirement_type": "ECOG score",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "ECOG"
},
{
"operator": "<=",
"value": 1,
"unit": "ECOG"
}
]
}
}
]
}
]
},
{
"line": "* Absolute neutrophil count ≥ 1,200/mm^3",
"criterions": [
{
"exact_snippets": "Absolute neutrophil count ≥ 1,200/mm^3",
"criterion": "absolute neutrophil count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1200,
"unit": "mm^3"
}
}
]
}
]
},
{
"line": "* Platelet count ≥ 75,000/mm^3",
"criterions": [
{
"exact_snippets": "Platelet count ≥ 75,000/mm^3",
"criterion": "platelet count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 75000,
"unit": "mm^3"
}
}
]
}
]
},
{
"line": "* Hemoglobin ≥ 10.0 g/dL",
"criterions": [
{
"exact_snippets": "Hemoglobin ≥ 10.0 g/dL",
"criterion": "hemoglobin",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": ">=",
"value": 10.0,
"unit": "g/dL"
}
}
]
}
]
},
{
"line": "* Bilirubin ≤ 3 times upper limit of normal (ULN)",
"criterions": [
{
"exact_snippets": "Bilirubin ≤ 3 times upper limit of normal (ULN)",
"criterion": "bilirubin level",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<=",
"value": 3,
"unit": "times ULN"
}
}
]
}
]
},
{
"line": "* AST ≤ 5 times ULN",
"criterions": [
{
"exact_snippets": "AST ≤ 5 times ULN",
"criterion": "AST",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 5,
"unit": "times ULN"
}
}
]
}
]
},
{
"line": "* Alkaline phosphatase ≤ 5 times ULN",
"criterions": [
{
"exact_snippets": "Alkaline phosphatase ≤ 5 times ULN",
"criterion": "alkaline phosphatase",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 5,
"unit": "times ULN"
}
}
]
}
]
},
{
"line": "* Urine protein < 1+ by urine dip stick OR proteinuria < 1 gm/24-hour collection",
"criterions": [
{
"exact_snippets": "Urine protein < 1+ by urine dip stick",
"criterion": "urine protein",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<",
"value": 1,
"unit": "+"
}
}
]
},
{
"exact_snippets": "proteinuria < 1 gm/24-hour collection",
"criterion": "proteinuria",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<",
"value": 1,
"unit": "gm/24-hour"
}
}
]
}
]
},
{
"line": "* QTc prolongation ≤ 500 msec",
"criterions": [
{
"exact_snippets": "QTc prolongation ≤ 500 msec",
"criterion": "QTc prolongation",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": "<=",
"value": 500,
"unit": "msec"
}
}
]
}
]
},
{
"line": "* No symptomatic congestive heart failure",
"criterions": [
{
"exact_snippets": "No symptomatic congestive heart failure",
"criterion": "symptomatic congestive heart failure",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* No unstable angina pectoris",
"criterions": [
{
"exact_snippets": "No unstable angina pectoris",
"criterion": "unstable angina pectoris",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* No cardiac arrhythmia",
"criterions": [
{
"exact_snippets": "No cardiac arrhythmia",
"criterion": "cardiac arrhythmia",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* No uncontrolled blood pressure, defined as systolic blood pressure > 150 mm Hg and/or diastolic blood pressure > 100 mm Hg",
"criterions": [
{
"exact_snippets": "uncontrolled blood pressure, defined as systolic blood pressure > 150 mm Hg",
"criterion": "systolic blood pressure",
"requirements": [
{
"requirement_type": "control",
"expected_value": "controlled"
},
{
"requirement_type": "value",
"expected_value": {
"operator": "<=",
"value": 150,
"unit": "mm Hg"
}
}
]
},
{
"exact_snippets": "uncontrolled blood pressure, defined as ... diastolic blood pressure > 100 mm Hg",
"criterion": "diastolic blood pressure",
"requirements": [
{
"requirement_type": "control",
"expected_value": "controlled"
},
{
"requirement_type": "value",
"expected_value": {
"operator": "<=",
"value": 100,
"unit": "mm Hg"
}
}
]
}
]
},
{
"line": "* No significant ECG abnormality within the past 14 days",
"criterions": [
{
"exact_snippets": "No significant ECG abnormality within the past 14 days",
"criterion": "ECG abnormality",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "not significant"
},
{
"requirement_type": "time frame",
"expected_value": "within the past 14 days"
}
]
}
]
},
{
"line": "* No New York Heart Association class III or IV disease",
"criterions": [
{
"exact_snippets": "No New York Heart Association class III or IV disease",
"criterion": "New York Heart Association class",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": "!=",
"value": 3,
"unit": "class"
}
},
{
"requirement_type": "severity",
"expected_value": {
"operator": "!=",
"value": 4,
"unit": "class"
}
}
]
}
]
},
{
"line": "* Negative pregnancy test",
"criterions": [
{
"exact_snippets": "Negative pregnancy test",
"criterion": "pregnancy test",
"requirements": [
{
"requirement_type": "result",
"expected_value": "negative"
}
]
}
]
},
{
"line": "* Fertile patients must use effective contraception",
"criterions": [
{
"exact_snippets": "Fertile patients",
"criterion": "fertility",
"requirements": [
{
"requirement_type": "status",
"expected_value": "fertile"
}
]
},
{
"exact_snippets": "must use effective contraception",
"criterion": "contraception use",
"requirements": [
{
"requirement_type": "necessity",
"expected_value": true
}
]
}
]
},
{
"line": "* No other malignancy within the past 5 years except basal cell or squamous cell skin cancer or carcinoma in situ of the cervix",
"criterions": [
{
"exact_snippets": "No other malignancy within the past 5 years",
"criterion": "other malignancy",
"requirements": [
{
"requirement_type": "time frame",
"expected_value": {
"operator": "<",
"value": 5,
"unit": "years"
}
},
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "except basal cell or squamous cell skin cancer",
"criterion": "basal cell or squamous cell skin cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "except ... carcinoma in situ of the cervix",
"criterion": "carcinoma in situ of the cervix",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* No history of allergic reaction to compounds of similar chemical or biological composition to AZD2171",
"criterions": [
{
"exact_snippets": "No history of allergic reaction to compounds of similar chemical or biological composition to AZD2171",
"criterion": "allergic reaction",
"requirements": [
{
"requirement_type": "history",
"expected_value": false
},
{
"requirement_type": "compound similarity",
"expected_value": "similar chemical or biological composition to AZD2171"
}
]
}
]
},
{
"line": "* No ongoing or active infection",
"criterions": [
{
"exact_snippets": "No ongoing or active infection",
"criterion": "infection",
"requirements": [
{
"requirement_type": "status",
"expected_value": false
}
]
}
]
},
{
"line": "* No psychiatric illness or social situation that would preclude study participation",
"criterions": [
{
"exact_snippets": "No psychiatric illness",
"criterion": "psychiatric illness",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No ... social situation that would preclude study participation",
"criterion": "social situation",
"requirements": [
{
"requirement_type": "impact on study participation",
"expected_value": false
}
]
}
]
},
{
"line": "* No other uncontrolled illness",
"criterions": [
{
"exact_snippets": "No other uncontrolled illness",
"criterion": "uncontrolled illness",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* More than 4 weeks since prior biologic therapy",
"criterions": [
{
"exact_snippets": "More than 4 weeks since prior biologic therapy",
"criterion": "time since prior biologic therapy",
"requirements": [
{
"requirement_type": "time elapsed",
"expected_value": {
"operator": ">",
"value": 4,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* More than 4 weeks since prior and no concurrent immunotherapy",
"criterions": [
{
"exact_snippets": "More than 4 weeks since prior ... immunotherapy",
"criterion": "immunotherapy",
"requirements": [
{
"requirement_type": "time since prior treatment",
"expected_value": {
"operator": ">",
"value": 4,
"unit": "weeks"
}
},
{
"requirement_type": "concurrent treatment",
"expected_value": false
}
]
}
]
},
{
"line": "* No colony-stimulating factors during the first course of study treatment",
"criterions": [
{
"exact_snippets": "No colony-stimulating factors during the first course of study treatment",
"criterion": "colony-stimulating factors",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Patients must have evidence of disease progression or new metastases after prior chemoembolization",
"criterions": [
{
"exact_snippets": "evidence of disease progression",
"criterion": "disease progression",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "new metastases",
"criterion": "new metastases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "prior chemoembolization",
"criterion": "prior chemoembolization",
"requirements": [
{
"requirement_type": "completion",
"expected_value": true
}
]
}
]
},
{
"line": "* No prior systemic chemotherapy for this cancer",
"criterions": [
{
"exact_snippets": "No prior systemic chemotherapy for this cancer",
"criterion": "prior systemic chemotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* No other concurrent chemotherapy",
"criterions": [
{
"exact_snippets": "No other concurrent chemotherapy",
"criterion": "concurrent chemotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* More than 4 weeks since prior hormonal therapy",
"criterions": [
{
"exact_snippets": "More than 4 weeks since prior hormonal therapy",
"criterion": "time since prior hormonal therapy",
"requirements": [
{
"requirement_type": "time elapsed",
"expected_value": {
"operator": ">",
"value": 4,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* See Disease Characteristics",
"criterions": [
{
"exact_snippets": "Disease Characteristics",
"criterion": "disease characteristics",
"requirements": [
{
"requirement_type": "N/A",
"expected_value": "refer to disease characteristics section"
}
]
}
]
},
{
"line": "* At least 6 weeks since prior radiofrequency ablation or other local ablative therapy",
"criterions": [
{
"exact_snippets": "At least 6 weeks since prior radiofrequency ablation",
"criterion": "time since prior radiofrequency ablation",
"requirements": [
{
"requirement_type": "time since treatment",
"expected_value": {
"operator": ">=",
"value": 6,
"unit": "weeks"
}
}
]
},
{
"exact_snippets": "At least 6 weeks since prior ... other local ablative therapy",
"criterion": "time since prior local ablative therapy",
"requirements": [
{
"requirement_type": "time since treatment",
"expected_value": {
"operator": ">=",
"value": 6,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* Patients must have evidence of disease progression or new metastases after prior radiofrequency ablation or other local ablative therapy",
"criterions": [
{
"exact_snippets": "evidence of disease progression",
"criterion": "disease progression",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "new metastases",
"criterion": "new metastases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "prior radiofrequency ablation",
"criterion": "prior radiofrequency ablation",
"requirements": [
{
"requirement_type": "completion",
"expected_value": true
}
]
},
{
"exact_snippets": "other local ablative therapy",
"criterion": "other local ablative therapy",
"requirements": [
{
"requirement_type": "completion",
"expected_value": true
}
]
}
]
},
{
"line": "* No prior external beam radiotherapy to the primary site",
"criterions": [
{
"exact_snippets": "No prior external beam radiotherapy to the primary site",
"criterion": "external beam radiotherapy to the primary site",
"requirements": [
{
"requirement_type": "prior treatment",
"expected_value": false
}
]
}
]
},
{
"line": "* No prior radiotherapy to ≥ 25% of the bone marrow",
"criterions": [
{
"exact_snippets": "No prior radiotherapy to ≥ 25% of the bone marrow",
"criterion": "prior radiotherapy to bone marrow",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<",
"value": 25,
"unit": "%"
}
}
]
}
]
},
{
"line": "* No concurrent radiotherapy",
"criterions": [
{
"exact_snippets": "No concurrent radiotherapy",
"criterion": "concurrent radiotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* See Disease Characteristics",
"criterions": [
{
"exact_snippets": "Disease Characteristics",
"criterion": "disease characteristics",
"requirements": [
{
"requirement_type": "N/A",
"expected_value": "see details"
}
]
}
]
},
{
"line": "* No concurrent combination antiretroviral therapy for HIV-positive patients",
"criterions": [
{
"exact_snippets": "No concurrent combination antiretroviral therapy for HIV-positive patients",
"criterion": "combination antiretroviral therapy",
"requirements": [
{
"requirement_type": "concurrency",
"expected_value": false
}
]
}
]
},
{
"line": "* No concurrent drugs or biologics with proarrhythmic potential",
"criterions": [
{
"exact_snippets": "No concurrent drugs or biologics with proarrhythmic potential",
"criterion": "concurrent drugs or biologics",
"requirements": [
{
"requirement_type": "proarrhythmic potential",
"expected_value": false
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [],
"miscellaneous_lines": [],
"failed_inclusion": [
{
"line": "* Not pregnant or nursing",
"criterions": [
{
"exact_snippets": "Not pregnant",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "status",
"expected_value": false
}
]
},
{
"exact_snippets": "not ... nursing",
"criterion": "nursing",
"requirements": [
{
"requirement_type": "status",
"expected_value": false
}
]
}
]
},
{
"line": "* At least 6 weeks since prior chemoembolization",
"criterions": [
{
"exact_snippets": "at least 6 weeks since prior chemoembolization",
"criterion": "time since prior chemoembolization",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 6,
"unit": "weeks"
}
}
]
}
]
}
],
"failed_exclusion": [],
"failed_miscellaneous": []
}